129 related articles for article (PubMed ID: 16946135)
1. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways.
Arrell DK; Elliott ST; Kane LA; Guo Y; Ko YH; Pedersen PL; Robinson J; Murata M; Murphy AM; Marbán E; Van Eyk JE
Circ Res; 2006 Sep; 99(7):706-14. PubMed ID: 16946135
[TBL] [Abstract][Full Text] [Related]
2. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
Hausenloy D; Wynne A; Duchen M; Yellon D
Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning with diazoxide prevents reoxygenation-induced rigor-type hypercontracture.
Abdallah Y; Wolf C; Meuter K; Piper HM; Reusch HP; Ladilov Y
J Mol Cell Cardiol; 2010 Jan; 48(1):270-6. PubMed ID: 19406125
[TBL] [Abstract][Full Text] [Related]
4. Delayed preconditioning by sevoflurane elicits changes in the mitochondrial proteome in ischemia-reperfused rat hearts.
Xiao YY; Chang YT; Ran K; Liu JP
Anesth Analg; 2011 Aug; 113(2):224-32. PubMed ID: 21659557
[TBL] [Abstract][Full Text] [Related]
5. Both metabolic inhibition and mitochondrial K(ATP) channel opening are myoprotective and initiate a compensatory sarcolemmal outward membrane current.
Irie H; Gao J; Gaudette GR; Cohen IS; Mathias RT; Saltman AE; Krukenkamp IB
Circulation; 2003 Sep; 108 Suppl 1():II341-7. PubMed ID: 12970257
[TBL] [Abstract][Full Text] [Related]
6. Selective mitochondrial adenosine triphosphate-sensitive potassium channel activation is sufficient to precondition human myocardium.
Pomerantz BJ; Robinson TN; Morrell TD; Heimbach JK; Banerjee A; Harken AH
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):387-92. PubMed ID: 10917958
[TBL] [Abstract][Full Text] [Related]
7. Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart.
Das B; Sarkar C
J Cardiovasc Pharmacol; 2006 Feb; 47(2):277-86. PubMed ID: 16495767
[TBL] [Abstract][Full Text] [Related]
8. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
Wang Y; Kudo M; Xu M; Ayub A; Ashraf M
J Mol Cell Cardiol; 2001 Nov; 33(11):2037-46. PubMed ID: 11708847
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1.
Arrell DK; Neverova I; Fraser H; Marbán E; Van Eyk JE
Circ Res; 2001 Sep; 89(6):480-7. PubMed ID: 11557734
[TBL] [Abstract][Full Text] [Related]
11. [The effects of diazoxide on myocardium function and the expressions of ERK and JNK in isolated spontaneous hypertension rat hearts].
Cao H; Chen XX; Gui B; Wang J; Duan SM; Zeng YM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb; 22(1):50-3. PubMed ID: 21186579
[TBL] [Abstract][Full Text] [Related]
12. Cardioprotective effects of mitochondrial KATP channels activated at different time.
Wei K; Min S; Long C
Chin Med J (Engl); 2004 May; 117(5):647-51. PubMed ID: 15161527
[TBL] [Abstract][Full Text] [Related]
13. Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine.
Headrick JP
J Mol Cell Cardiol; 1996 Jun; 28(6):1227-40. PubMed ID: 8782064
[TBL] [Abstract][Full Text] [Related]
14. The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs.
Végh A; Parratt JR
Br J Pharmacol; 2002 Dec; 137(7):1107-15. PubMed ID: 12429584
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
Hassouna A; Loubani M; Matata BM; Fowler A; Standen NB; Galiñanes M
Cardiovasc Res; 2006 Feb; 69(2):450-8. PubMed ID: 16330008
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment with an adenosine A1 receptor agonist and lidocaine: a possible alternative to myocardial ischemic preconditioning.
Canyon SJ; Dobson GP
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):371-7. PubMed ID: 16077401
[TBL] [Abstract][Full Text] [Related]
17. [Diabetes counteracts the protective effect of the diazoxide preconditioning on ischemic reperfused rat heart].
Han JS; Yan DM; Zhu HY; Wang ZW
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1185-8. PubMed ID: 20021914
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: effects of a protein phosphatase inhibitor, fostriecin.
Armstrong SC; Kao R; Gao W; Shivell LC; Downey JM; Honkanen RE; Ganote CE
J Mol Cell Cardiol; 1997 Nov; 29(11):3009-24. PubMed ID: 9405176
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
Weinbrenner C; Liu GS; Cohen MV; Downey JM
J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
[TBL] [Abstract][Full Text] [Related]
20. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart.
McCully JD; Uematsu M; Parker RA; Levitsky S
J Thorac Cardiovasc Surg; 1998 Jul; 116(1):154-62. PubMed ID: 9671910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
